0001666071-20-000208.txt : 20200720 0001666071-20-000208.hdr.sgml : 20200720 20200720184711 ACCESSION NUMBER: 0001666071-20-000208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200716 FILED AS OF DATE: 20200720 DATE AS OF CHANGE: 20200720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christiansen Andrew CENTRAL INDEX KEY: 0001805400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 201037252 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_159528521573856.xml FORM 4 X0306 4 2020-07-16 0 0001666071 Cardlytics, Inc. CDLX 0001805400 Christiansen Andrew C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Financial Officer Common Stock 2020-07-16 4 M 0 4707 24.48 A 15420 D Common Stock 2020-07-16 4 S 0 4707 79 D 10713 D Common Stock 2020-07-20 4 M 0 2518 24.48 A 13231 D Common Stock 2020-07-20 4 S 0 2518 79 D 10713 D Employee Stock Option (Right to Buy) 24.48 2020-07-16 4 M 0 4707 0 D 2027-04-01 Common Stock 4707.0 4667 D Employee Stock Option (Right to Buy) 24.48 2020-07-20 4 M 0 2518 0 D 2027-04-01 Common Stock 2518.0 2149 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. /s/ Kirk L. Somers, Attorney-in-Fact 2020-07-20